Lung Cancer Non-Small Cell Cancer (NSCLC) Unknown Status Phase 2 Trials for Cisplatin (DB00515)

Also known as: Non - Small Cell Lung Cancer NSCLC / Carcinoma, Non-Small-Cell Lung / Non-Small-Cell Lung Carcinoma (NSCLC) / Non-Small-Cell Lung Carcinoma / Nonsmall Cell Lung Cancer / Lung Cancer(NSCLC) / Non-Small Cell Lung Cancer / Non-Small-Cell Lung Cancer (NSCLC) / NSCLC (Non-Small Cell Lung Cancer) / Non Small Cell Lung Cancer (NSCLC) / Lung Cancer (Non-Small Cell) / NSCLC, Non Small Cell Lung Cancer / Non-small Cell Lung Cancers / Lung Cancer, Nonsmall Cell / Non-Small Cell Lung Carcinoma / Lung Cancer Non-Small Cell / Non-Small-Cell Lung Cancer / Non-Small Cell Lung Cancer (NSCLC) / Non Small Cell Lung Cancer / Non-Small Cell Lung Carcinoma (NSCLC) / Carcinoma, Non-Small Cell Lung / Lung Cancer, Non-Small Cell / Non Small-cell Lung Cancer / NSCLC Non-small Cell Lung Cancer / NSCLC / Non Small Cells Lung Cancer / Non-Small Cell Lung Cancer(NSCLC) / Non- Small Cell Lung Cancer / Lung Cancer - Non Small Cell / Lung Cancer (NSCLC) / Non Small Cell Lung Cancer NSCLC / Non-Small-Cell-Lung Cancer (NSCLC) / Non-Small-Cell-Lung Cancer / Non-small cell lung cancer (disorder) / Non-small cell lung cancer NOS

IndicationStatusPhase
DBCOND0046916 (Lung Cancer Non-Small Cell Cancer (NSCLC))Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01784549Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)DiseaseTreatment
NCT01424709Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)Treatment
NCT01401192Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase ExpressionTreatment
NCT01192243Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer PatientsTreatment
NCT01019798Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung CancerTreatment
NCT01003964Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IVTreatment
NCT00178698Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic TumorsTreatment
NCT00620269Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC IIITreatment
NCT00270582A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung CancerTreatment
NCT01131429A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR MutationsTreatment